Supplements for Weight Loss on a GLP-1: 16 Supplements Evidence-Graded Against PubMed

Sixteen popular weight-loss supplements graded A through D against verified PubMed primary sources. Only three reach grade A or B for weight loss with credible RCT evidence: berberine (Asbaghi 2020 meta −2.07 kg)^[1], MCT oil as a long-chain triglyceride replacement (Mumme 2015 meta −0.51 kg vs LCT)^[4], and green tea catechins (Hursel 2009 meta −1.31 kg)^[5]. Glucomannan^[9], psyllium^[10], CLA^[8], and apple cider vinegar reach grade B with caveats. The remaining 9 supplements have grade C or D evidence — either animal-only data, a single underpowered trial, no human weight-loss data at all, or evidence so methodologically weak that it disappears under quality filters. Even the best supplements produce roughly 1-5% of GLP-1 magnitude. Lemon balm has 2,700 monthly searches and zero human weight-loss RCTs. Marketing volume does not equal evidence. Here is the verified evidence map.

The grading scale

• Grade A: Multiple RCTs converge on a consistent effect; meta-analysis with statistically significant magnitude; mechanism well-characterized.
• Grade B: Single decent meta-analysis or multiple RCTs with directional signal; modest magnitude; some methodological caveats.
• Grade C: Animal or pilot human data only; single underpowered RCT; or evidence that disappears under quality filters.
• Grade D: No human RCT evidence for weight loss specifically; folklore or marketing claims only.

Grade A: Berberine

We covered berberine in detail in our dedicated berberine vs GLP-1 article. The headline: Asbaghi 2020^[1] meta-analyzed 12 RCTs and reported a mean weight reduction of −2.07 kg (95% CI −3.09 to −1.05, p<0.001) and BMI reduction of −0.47 kg/m² over a median 12-week follow-up. Yin 2008^[2] anchors the diabetes side. The Liu 2010 PK study^[3] showed approximately 0.36% oral bioavailability in rats — the bottleneck that limits any “nature's Ozempic” magnitude argument.

Grade: A. Real, replicable, well-characterized mechanism, but ~5-8% of GLP-1 magnitude. Reasonable adjunct; not a substitute.

Grade B: MCT oil (as a fat replacement)

Mumme and Stonehouse 2015^[4] meta-analyzed 13 RCTs (n=749) of medium-chain triglycerides as a replacement for long-chain triglycerides in the diet. Pooled effect: −0.51 kg (95% CI −0.80 to −0.23, p<0.001) for body weight; −1.46 cm waist; −0.79 cm hip. Effect was consistent across trials but modest in absolute magnitude.

Critical caveat: MCT oil works as an LCT replacement, not as an additive caloric source. Bulletproof coffee (added MCT oil + butter on top of normal eating) is not the trial design. For patients to capture the modest benefit, they need to substitute MCT for an equal-calorie amount of LCT (typically olive oil or other long-chain fat).

Grade: B. Real but modest, ~1-2% of GLP-1 magnitude. Cost is not negligible (~$15-30/month for therapeutic doses).

For the keyword-target deep dive on the “how to use MCT oil for weight loss” cluster, see our dedicated MCT oil for weight loss evidence review. That article walks through Mumme 2015^[4] in detail, the St-Onge 2008 16-week head-to-head MCT vs olive oil trial (PMID 18326600, -1.67 kg), the foundational thermogenesis and satiety mechanism papers (Scalfi 1991 PMID 2021124; St-Onge 2003 PMIDs 12532160 + 12975635; Van Wymelbeke 2001 PMID 11684530; Van Wymelbeke 1998 PMID 9701177), the cardiovascular safety contrast with coconut oil (Neelakantan 2020 Circulation PMID 31928080: +10.47 mg/dL LDL for coconut, neutral for fractionated MCT), the C8 vs C10 vs C12 lauric category dispute, the caloric- substitution math that determines whether MCT actually produces weight loss, the Bulletproof-coffee error, GLP-1 fat-tolerance guidance during titration, and side-effect titration.

Grade B: Green tea catechins / EGCG

Hursel 2009^[5] meta-analyzed 11 RCTs of green tea catechin preparations (typically standardized to ~270 mg EGCG/day with caffeine). Pooled effect: −1.31 kg body weight, p<0.001. The effect was modulated by ethnicity (Asian populations showed larger responses) and by habitual caffeine intake (regular caffeine consumers showed smaller effects due to catechin-caffeine interaction).

Decaffeinated green tea preparations show minimal benefit; the catechin + caffeine combination is what drives the effect. Hepatotoxicity has been rarely reported with high-dose green tea extract supplements (not with green tea as a beverage); USP and Cochrane note this as a low- but-real signal warranting label warnings.

For the keyword-target deep dive on the “is matcha good for weight loss” cluster, see our dedicated matcha for weight loss evidence review. That article walks through Hursel 2009^[5]in detail, the Dulloo 1999 24-hour-energy-expenditure landmark paper (PMID 10584049, +4% EE with green tea extract vs no effect with caffeine alone), the COMT-inhibition mechanism (Westerterp-Plantenga 2010 PMID 20156466; Rains 2011 PMID 21115335), the Cochrane 2012 skeptical reading (Jurgens PMID 23235664), the matcha-specific catechin concentration story (Kochman 2020 PMID 33375458 verbatim “best condensed source”; Jakubczyk 2020 PMID 32290537), the EGCG hepatotoxicity signal (Lambert 2010 PMID 19883714 mouse model; Mazzanti 2015 PMID 25975988 human case reports), iron-absorption interaction (Asakura 2009 PMID 19063766), and L-theanine + caffeine cognition synergy (Owen 2008 PMID 18681988).

Grade: B. Real but modest, ~3-5% of GLP-1 magnitude. Decaffeinated forms minimal benefit.

Grade B: Glucomannan and psyllium fiber

Glucomannan (konjac fiber): Sood 2008^[9] meta-analyzed 14 RCTs (n=531). Pooled body weight effect: −0.79 kg (95% CI −1.53 to −0.05). Also reduced total cholesterol by 19.28 mg/dL and triglycerides by 11.08 mg/dL. Mechanism: viscous fiber gels in the stomach, expanding gastric volume and delaying emptying — satiety, not metabolism.

Psyllium husk (Plantago ovata): Pal 2011^[10] randomized 66 overweight adults to psyllium plus a healthy diet over 12 weeks. Modest body composition and lipid improvements. Multiple subsequent meta-analyses confirm a similar profile: ~0.8-1.5 kg weight effect and meaningful LDL/triglyceride improvements.

Both fibers carry a real choking risk if not taken with adequate water. Both are inexpensive, safe in renal disease, and support the satiety side of GI tolerance on a GLP-1.

Grade: B. Real but modest, ~2-3% of GLP-1 magnitude. Inexpensive and safe; reasonable adjuncts.

Grade B: Conjugated linoleic acid (CLA)

Whigham 2007^[8] meta-analyzed 18 RCTs of CLA supplementation. At 3.2 g/day (the typical effective dose), fat mass loss was approximately −0.09 kg per week versus placebo, plateauing after about 6 months. That works out to roughly −4.7 kg of fat over 6 months at the high dose — not trivial, but with meaningful caveats: GI upset (diarrhea, fatty stools), insulin resistance reported in some diabetic subgroups, and cost ($30-50/month) that erodes cost-effectiveness.

Grade: B. Real but modest, ~3-5% of GLP-1 magnitude. Side effects and cost limit value.

Grade B: Apple cider vinegar (with caveats)

Apple cider vinegar is heavily marketed for weight loss. The published evidence is thin. The Khezri 2018 trial in the Journal of Functional Foods (not PubMed- indexed at search time) reported an additional ~1.2 kg weight loss vs diet alone in 39 patients on a calorie- restricted diet. Launholt 2020^[14] in European Journal of Nutrition systematically reviewed the ACV literature and concluded that evidence for weight or metabolic effects is insufficient due to methodological limitations across the trial base.

A separate 2024 BMJ Nutrition Prevention Health trial in Lebanese adolescents (Abou-Khalil 2024) initially reported large effects but was retracted in September 2025 due to improbable data characteristics. Treat any weight-loss ACV claim sourced to that paper as void.

Side effects: dental erosion with prolonged daily exposure; esophageal irritation if undiluted. Cost: ~$1-3/month (cheap vinegar from a grocery store).

For the keyword-target deep-dive on the TikTok-viral “how to drink apple cider vinegar for weight loss in 1 week” cluster, see our dedicated apple cider vinegar 1-week weight-loss evidence review. That article walks through Kondo 2009 (PMID 19661687) in detail, the Castagna 2025 meta-analysis (PMID 41010525, SMD −0.39), the retraction of the Abou-Khalil 2024 paper, the wrong-paper PMID hallucination for the “Khezri 2018” citation that circulates online, and the harm-minimization protocol if a patient chooses to use ACV despite the modest evidence.

Grade: B with caveats. Effect is small, diet-context dependent, and the literature is methodologically weak. Cheap and harmless in moderation, but unlikely to meaningfully move the needle.

Grade C: Ashwagandha (Withania somnifera)

Choudhary 2017^[12] randomized 52 chronically stressed adults to ashwagandha or placebo for 8 weeks. The trial reported significant improvements in stress, food cravings, and a directional improvement in body weight, but the exact weight effect size was not disclosed in the available abstract. The weight-loss arm of the ashwagandha evidence base is essentially this one underpowered trial in a stressed-adult population.

Cortisol-reduction evidence (Salve 2019, Lopresti 2019, covered in our stress and cortisol article) is somewhat stronger, but cortisol reduction is not weight loss.

For the deep dive on two common questions about this topic — “does ashwagandha help with weight loss” and “can ashwagandha cause weight loss” — covering the Choudhary 2017 RCT verbatim, the cortisol → stress-eating → visceral-fat physiology, the “can ashwagandha cause weight GAIN?” paradoxical-reports question (answered by the absence of RCT evidence), the thyroid pathway, KSM-66 vs Sensoril vs Shoden form comparison, and the full safety + drug interaction matrix, see our dedicated ashwagandha weight-effects evidence review.

Grade: C. Plausible adjunct for stress eating; not a primary weight intervention. Watch for rare hepatotoxicity case reports.

Grade D / oppositional: Creatine monohydrate

Creatine is the most-misunderstood supplement on the list. It is one of the most rigorously-studied performance supplements with strong evidence for muscle preservation and strength gains during resistance training. But for weight loss, creatine works in the opposite direction: initial water retention from muscle creatine loading typically increases body weight by 0.5-2 kg in the first weeks. Long-term, creatine supports lean mass preservation in caloric deficit (Forbes 2019 meta-analysis: lean mass +0.68 kg, especially when paired with resistance training).

For a GLP-1 patient who is already losing fat and trying to preserve lean mass, creatine 5 g/day plus resistance training is a defensible adjunct — it tilts the body composition outcome more favorably without preventing fat loss. But it does not cause weight loss and will increase the scale number short-term.

Grade: D for weight loss; A for muscle preservation when used with resistance training. See our exercise pairing article.

Grade C: Magnesium

Magnesium is metabolically important and many adults are marginally deficient. Recent meta-analyses (Askari 2021 and others) of magnesium supplementation and body weight report modest BMI reductions (~−0.21 kg/m²) without significant body weight effects overall. Subgroup analyses in obese patients show waist circumference reductions of ~2 cm. Magnesium is useful for muscle cramps, sleep, and insulin sensitivity in deficient patients; it is not a weight-loss agent.

Grade: C for weight loss; B for related metabolic support in deficient adults.

For the form-by-form comparison of the 8 common magnesium types (glycinate, citrate, oxide, malate, L-threonate, chloride, taurate, sulfate) with bioavailability, GI side effects, and weight-loss evidence for each — including why magnesium oxide produces 24-hour urinary excretion no different from placebo (Walker 2003, PMID 14596323) and why magnesium L-threonate marketing has no human weight-loss RCT support — see our dedicated magnesium-and-weight-loss evidence review. Magnesium citrate is also a defensible OTC option for mild GLP-1 constipation; magnesium glycinate is the gentle-GI first-line during titration.

Grade D: Collagen peptides

The Proksch 2014 RCT^[13] randomized 69 women to oral collagen peptides or placebo for 8 weeks. The trial showed significant improvement in skin elasticity (the primary endpoint), but did not measure or report weight loss. Collagen peptides are protein, so they contribute to protein satiety like any other protein source, but there is no evidence that the collagen-specific composition produces weight loss above and beyond what an equivalent protein dose would.

Useful for skin elasticity in midlife women; useless for weight loss directly. Relevant for patients losing weight rapidly on a GLP-1 who are concerned about loose skin (see our loose skin article).

Grade: D for weight loss; B for skin elasticity in healthy mid-life women.

Grade C: Cinnamon

Cinnamon has a weak, statistically detectable effect on fasting glucose in T2D patients (Allen 2013 Annals of Family Medicine meta-analysis: ~−24.6 mg/dL fasting glucose, no significant A1c effect). The Allen meta did not report weight as a primary outcome and the broader cinnamon literature does not support a meaningful weight effect. The TikTok “cinnamon coffee for weight loss” trend is not evidence-based.

Grade: C. Modest glucose effect, no meaningful weight effect.

Grade C: Turmeric / curcumin

Turmeric (the dried rhizome of Curcuma longa) contains roughly 2 to 5 percent curcuminoids by weight, of which curcumin is the dominant polyphenol. The Akbari 2019 meta-analysis (PMID 31249528, 21 RCTs, n=1,604 metabolic-syndrome adults) reported pooled body-weight SMD −0.23 (P < 0.01), BMI SMD −0.37, waist-circumference SMD −0.25, and a large leptin SMD of −0.97. The Panahi 2017 phytosomal-curcumin NAFLD RCT (PMID 28158893) showed BMI −0.99 vs −0.15 kg/m² (p=0.003) and steatosis improvement in 75% vs 4.7% on placebo (p<0.001) over 8 weeks. The mechanism is anti-inflammatory (NF-κB inhibition, AMPK activation, PPAR-γ modulation), so effects are largest in inflammation-driven phenotypes (NAFLD, elevated CRP, metabolic syndrome).

Curcumin has notoriously poor oral bioavailability (Shoba 1998 PMID 9619120: serum levels “undetectable or very low” after 2 g curcumin alone; piperine increases bioavailability by +2,000%). Most positive trials used bioavailability-enhanced formulations (Meriva phytosome, Theracurmin, Longvida, BCM-95, curcumin + piperine). Raw culinary turmeric has minimal systemic effect. Safety signal: Lombardi 2021 (PMID 32656820) documents 7 + 23 cases of acute cholestatic hepatitis under high-bioavailability gram-scale formulations; curcumin is also an iron chelator (Jiao 2009 PMID 18815282), so avoid in iron-deficiency anemia.

For the deep-dive covering the Akbari 2019 meta-analysis verbatim, the Shoba 1998 piperine bioavailability finding, the Panahi 2017 phytosomal-curcumin NAFLD RCT, the NF-κB/AMPK/PPAR-γ mechanism story, the bioavailability-formulation comparison (Meriva vs Theracurmin vs Longvida vs BCM-95 vs curcumin+piperine), the Lombardi 2021 hepatotoxicity case series, the iron-chelation caution, the full drug-interaction matrix (anticoagulants, antiplatelets, antidiabetics, levothyroxine), and the “golden milk” debunk, see our dedicated does turmeric help with weight loss? evidence review.

Grade: C. Small but real effect (SMD −0.23 body weight) in inflammation-driven obesity; magnitude 10 to 20 times smaller than FDA-approved AOMs; documented hepatotoxicity risk at high-bioavailability gram-scale doses.

Grade D: Garcinia cambogia (HCA)

Garcinia cambogia (hydroxycitric acid) is one of the most heavily marketed weight-loss supplements. Onakpoya 2011^[6] meta-analyzed 12 RCTs and reported a pooled weight effect of −0.88 kg (95% CI −1.75 to 0.00) — statistically borderline. When the analysis was restricted to high-quality RCTs only, the effect disappeared entirely. The signal in the meta is driven by low-quality, short-duration, small-sample trials.

Safety: rare case reports of hepatotoxicity (FDA Consumer Update 2009, multiple subsequent case reports). The magnitude is too small to justify any risk.

Grade: D. Minimal effect that disappears with quality filtering. Marketing exceeds evidence substantially.

Grade C: Chromium picolinate

Onakpoya 2013^[7] meta-analyzed 20 RCTs of chromium picolinate. The pooled body weight effect was statistically significant but the authors explicitly noted that the clinical magnitude was unclear and the effect was driven by trials of variable quality. Chromium is metabolically active in patients with documented chromium deficiency (rare); for the general population it does not produce meaningful weight loss.

Grade: C. Statistically detectable but clinically marginal.

Grade D: Lemon balm (Melissa officinalis)

Lemon balm has 2,700 monthly searches in the US for weight loss. The Heshmati 2020^[11] meta-analysis of 7 RCTs on lemon balm and cardiometabolic outcomes explicitly did not measure body weight. Lipids, blood pressure, and glucose were unchanged. The remaining lemon balm literature is on anxiety and stress, where it shows modest benefit. There is no human RCT evidence for lemon balm as a weight-loss intervention. For the keyword-target deep-dive examining each TikTok mechanism story (lemon balm tea, cortisol/stress-eating, ACV combination products, the rosmarinic-acid GABA-T mechanism) against the actual PubMed evidence, plus the thyroid caution and full drug-interaction matrix, see our dedicated lemon balm for weight loss evidence review.

Grade: D. Marketing volume vastly exceeds evidence. Useful for anxiety; not for weight.

Grade D: Moringa (Moringa oleifera)

Moringa oleifera (the “drumstick tree” / “miracle tree”) has 1,200 monthly searches for “does moringa help with weight loss.” The placebo-controlled human evidence base is small and largely null: Taweerutchana 2017 (PMID 29317895, 32 T2DM patients, 8 g/day x 4 weeks) found “no effect on glycemic control”; Díaz-Prieto 2022 (PMID 35565903, 65 prediabetes patients, 2.4 g/day x 12 weeks, double-blind) found “no differences in the biomarker's change scores were found between the groups.” The single human BMI signal (Ezzat 2020 PMID 31911179) was a 15-woman, open-label arm appended to a rat experiment with no placebo control and no magnitude reported in the abstract. Moringa leaf is genuinely nutrient-dense (~27 g protein, ~2,000 mg calcium, ~600 mg vitamin C per 100 g dried leaf) and a defensible micronutrient adjunct; it is not a weight-loss intervention by the modern RCT standard. Caution for patients on warfarin (high vitamin K content) and theoretical additive hypoglycemia with insulin / sulfonylureas / GLP-1s. For the keyword-target deep-dive on each placebo-controlled RCT verbatim, the rat MC4R/PPAR-alpha mechanism, seed isothiocyanate in vitro evidence, the nutrient-density argument, drug interactions, pregnancy guidance, and the order-of-magnitude gap vs Wegovy / Zepbound, see our dedicated moringa for weight loss evidence review.

Grade: D. Nutrient-dense food, plausible traditional medicine; not a weight-loss intervention. Mostly null placebo-controlled human RCTs at supplement-realistic doses.

Grade D: L-Lysine

L-lysine has 2,300+ monthly searches for weight loss. Our verification subagent searched PubMed extensively and found no human RCT evidence for L-lysine causing weight loss. The mechanism stories (carnitine biosynthesis, ketone metabolism) are speculative. More than 94% of US adults already meet the WHO/FAO lysine requirement from diet alone, so supplementation is unlikely to fill any meaningful nutritional gap. For the keyword-target deep-dive examining each TikTok mechanism story (carnitine biosynthesis, cortisol/stress-eating, HCA-Garcinia combo products) against the actual PubMed evidence, plus safety (NOAEL 6,000 mg/day per Hayamizu 2019 PMID 30661148 + Cynober 2020 PMID 33000163), see our dedicated L-lysine for weight loss evidence review.

Grade: D. UNVERIFIED for weight loss in humans.

Grade D: Vitamin B12 (cobalamin)

Vitamin B12 has 1,100+ monthly searches for weight loss. The TikTok and med-spa “B12 shots boost metabolism and burn fat” claim has zero RCT support in non-deficient adults. The B12-obesity epidemiology is real but runs in the wrong direction for an intervention: Sun 2019 NHANES (PMID 31316466, n=9,075) found serum B12 inversely associated with obesity (adjusted OR 0.71 for highest vs lowest quartile), i.e. obese adults are MORE likely to have low B12 — not that supplementing B12 will cause weight loss. The Markun 2021 meta-analysis (PMID 33809274) of 16 RCTs in 6,276 non-deficient adults concluded B12 supplementation is “likely ineffective for improving cognitive function and depressive symptoms in patients without advanced neurological disorders” — same logic applies to the “B12 boosts energy and weight loss” claim. The real B12 issue in the GLP-1 era is metformin-induced B12 depletion (Aroda 2016 DPPOS PMID 26900641, odds ratio 1.13 per year of metformin use) — correct that with oral cyanocobalamin 1,000 mcg/day if deficient. NIH ODS “Dietary Supplements for Weight Loss” fact sheet does NOT list B12. For the keyword-target deep-dive examining each B12 mechanism story (energy boost, B12 shots, metformin co-treatment, vegan supplementation, forms comparison) against the actual PubMed evidence, see our dedicated vitamin B12 for weight loss evidence review.

Grade: D. UNVERIFIED for weight loss in non-deficient adults. Legitimate role: correct documented deficiency.

Grade D: Vitamin D (cholecalciferol / ergocalciferol)

Vitamin D has 1,000+ monthly searches for weight loss. The epidemiologic association between low 25-hydroxyvitamin D and obesity is robust (Pereira-Santos 2015 meta-analysis, PMID 25688659, Obes Rev, 23 studies in 29,882 adults: 35% higher vitamin D deficiency prevalence in obese vs eutrophic subjects) — but the causal arrow points the wrong way. The Vimaleswaran 2013 bidirectional Mendelian randomization (PMID 23393431, PLoS Med, 21 cohorts n=42,024 + GIANT n=123,864) concluded verbatim: “a higher BMI leads to lower 25(OH)D, while any effects of lower 25(OH)D increasing BMI are likely to be small.” Mechanism is volumetric dilution in a large fat mass (Drincic 2012, PMID 22262154, Obesity), not sequestration. Two large RCTs of supplementation are both negative: Mason 2014 (PMID 24622804, Am J Clin Nutr, n=218 postmenopausal women, 2,000 IU/d D3 + intensive lifestyle weight loss for 12 months) found no difference vs placebo (-7.1 kg vs -7.4 kg); VITAL Chou 2021 (PMID 33513226, JCEM, n=771 with DXA from the 25,871-participant parent trial) found no effect of 2,000 IU/d D3 on weight, BMI, or body composition in overweight/obese adults over 2 years. Mallard 2016 meta-analysis (PMID 27604772) showed weight loss itself raises 25(OH)D modestly, confirming reverse causation. For the keyword-target deep-dive examining each mechanism story (volumetric dilution, GLP-1 mobilization, D2 vs D3, K2 co-supplementation) against the actual PubMed evidence, see our dedicated vitamin D for weight loss evidence review.

Grade: D. UNVERIFIED for weight loss in non-deficient adults. Legitimate role: bone health, correcting documented deficiency, post-bariatric supplementation.

The summary table

Comparator anchors: GLP-1 magnitudes

• Semaglutide 2.4 mg (STEP-1): −14.9% body weight at 68 weeks^[15]
• Tirzepatide 15 mg (SURMOUNT-1): −20.9% at 72 weeks^[16]

For a 100 kg starting weight, that's −15 to −21 kg. Even the highest-grade supplement (berberine at −2.07 kg) is roughly 1/7 to 1/10 the magnitude. Patients seeking 10%+ weight loss are not going to get there on supplements alone.

Regulatory context

Dietary supplements in the US cannot legally make disease treatment claims (DSHEA 1994). Weight loss is not a disease per se but weight-loss claims still attract FTC scrutiny when unsupported. FDA does not pre-approve supplement efficacy or label accuracy. Independent testing programs (USP, NSF, ConsumerLab) repeatedly find purity and potency variation across supplement brands, especially in weight-loss product categories.

The NIH Office of Dietary Supplements maintains a weight-loss supplement factsheet that is more conservative than published meta-analyses and emphasizes clinical relevance over statistical significance. Their bottom line aligns closely with this article: the evidence base for weight-loss supplements is thin, and patients seeking meaningful weight loss should focus on lifestyle changes and FDA-approved pharmacotherapy.

The honest patient framing

• If you want significant weight loss (≥10%): supplements are not going to deliver. GLP-1s (semaglutide, tirzepatide, orforglipron), Qsymia, or bariatric surgery are the evidence-based options.
• If you're already on a GLP-1 and want a metabolic-support adjunct: berberine (if not on a CYP3A4-sensitive medication), green tea catechins, and fiber (glucomannan or psyllium) have the strongest supplement evidence.
• If you're trying to preserve lean mass on a GLP-1: creatine 5 g/day plus resistance training is the best-evidenced supplement intervention. See our exercise pairing article.
• If you're on a GLP-1 and worried about loose skin: oral collagen peptides have evidence for skin elasticity (Proksch 2014) but not for weight loss. See our loose skin article.
• Skip: garcinia cambogia, chromium picolinate, lemon balm for weight loss, L-lysine for weight loss, and any supplement marketed as “nature's Ozempic.”

Bottom line

• 16 popular weight-loss supplements graded against PubMed primary sources.
• Only berberine reaches grade A. Only six others reach grade B. Nine are grade C or D.
• Even the best supplements produce roughly 1-5% of GLP-1 magnitude.
• Marketing volume does not equal evidence: lemon balm and L-lysine have thousands of monthly searches and zero human weight-loss RCTs.
• Creatine is oppositional: it increases scale weight short-term but supports lean mass preservation when paired with resistance training.
• For meaningful weight loss, FDA-approved pharmacotherapy (GLP-1s or Qsymia) and lifestyle change are the evidence-based options.

What are the best metabolism booster pills for weight loss?

Honest answer: there is no over-the-counter “metabolism booster pill” that produces clinically meaningful weight loss. The supplements most often marketed as metabolism boosters — caffeine, green tea extract / EGCG, capsaicin, L-carnitine, raspberry ketones, and synephrine (bitter orange) — show small-to-no effect in Cochrane systematic reviews and USPSTF evidence syntheses (typical mean weight reduction <2% at 12 weeks, with high heterogeneity).

On our evidence-graded scale above:

• Green tea catechins / EGCG reach grade B with ~0.5–2 kg effect over 12 weeks (see grade B section above).
• Caffeine, capsaicin, L-carnitine, raspberry ketones, and bitter orange are grade C/D — modest to no effect, with synephrine carrying cardiovascular stimulant risk that disqualifies it for any patient on a GLP-1 (which already produces a 2–4 bpm baseline heart-rate shift).
• For comparison: semaglutide produces −14.9% at 68 weeks (STEP-1), tirzepatide −20.9% at 72 weeks (SURMOUNT-1) — roughly 5–20× the magnitude of any supplement category.

If you want a metabolism-relevant adjunct backed by evidence, berberine (grade A here) and creatine (for lean-mass preservation when paired with resistance training) are the defensible picks. None of these are substitutes for FDA-approved pharmacotherapy.

Related research and tools

• Best oral peptides for weight loss: evidence vs hype — the BPC-157 / TB-500 / AOD-9604 / tesamorelin regulatory-status companion review
• Berberine vs GLP-1: dedicated deep-dive
• Berberine vs Ozempic: is berberine really “nature's Ozempic”? — consumer-search-intent companion to the technical evidence review. Mechanism (AMPK vs GLP-1R), magnitude (~1:7 to 1:10 ratio), bioavailability (0.36% in rats vs ~80% subcutaneous), and the dihydroberberine question side by side.
• Exercise pairing on a GLP-1 — for the creatine + resistance training context
• Magnesium for weight loss: which form is best — the 8 common magnesium forms compared (glycinate, citrate, oxide, malate, L-threonate, chloride, taurate, sulfate) with bioavailability, GI side effects, and weight-loss evidence. Covers the Askari 2021 meta-analysis (PMID 32654500, 32 RCTs, BMI −0.21 kg/m²), Rafiee 2021 waist-circumference subgroup finding (PMID 32718360), Walker 2003 bioavailability head-to-head (PMID 14596323), and the 4 drug-interaction classes (levothyroxine, tetracyclines, fluoroquinolones, bisphosphonates) requiring 2-hour separation.
• Loose skin after rapid GLP-1 weight loss — for the collagen peptide context
• Does collagen help with weight loss? — dedicated deep-dive on the collagen-and-weight-loss question (~900/mo). Zero direct-weight-loss RCT (live PubMed search on 2026-05-16 returned no matches), collagen is an INCOMPLETE protein with very low tryptophan + low leucine + very low DIAAS (Phillips & Van Loon 2011 PMID 22150425), and is INFERIOR to whey/casein/eggs for muscle protein synthesis. The skin-elasticity evidence base (Proksch 2014 PMID 23949208, Bolke 2019 PMID 31627309, Choi 2014 PMID 24131075, Pu 2023 meta PMID 37432180, de Miranda 2021 meta PMID 33742704) is real and modest but separate from weight loss. Zdzieblik 2015 (PMID 26353786) + Jendricke 2019 (PMID 31010031) body-composition signal requires resistance training as the load-bearing intervention.
• What is the pink salt trick for weight loss? Honest evidence review — deep-dive on the TikTok-viral “pink salt trick” (Himalayan pink salt + warm water + lemon, sometimes ACV). Zero peer-reviewed RCTs support weight loss. Pink salt is ~98% sodium chloride per Fayet-Moore 2020 (Foods, PMID 33086585), with trace minerals at nutritionally irrelevant quantities and one Himalayan sample exceeding Australia's maximum lead contaminant level. Sodium drives blood pressure not fat loss (He 2013 BMJ PMID 23558162, Aburto 2013 BMJ PMID 23558163); AHA caps sodium at ≤2,300 mg/day (ideal 1,500 mg/day). Sibling myth-buster to the gelatin trick below.
• The gelatin trick for weight loss: evidence vs hype — deep-dive on the TikTok-viral gelatin / Jell-O recipe (~10K/mo cluster). Covers gelatin's composition (hydrolyzed collagen, PDCAAS ~0.08-0.10), satiety evidence (Veldhorst 2009 PMID 19185957, Hochstenbach-Waelen 2009 PMID 19864402, Nieuwenhuizen 2009 PMID 19017422), skin / collagen-peptide trials (Bolke 2019 PMID 31627309, Pu 2023 meta PMID 37432180, de Miranda 2021 meta PMID 33742704), the “leaky gut” claim (Camilleri 2019 PMID 31076401, Gut), and why the order-of-magnitude gap (~20×) vs FDA-approved AOMs (Wegovy STEP-1, Zepbound SURMOUNT-1) means gelatin is not a primary weight-loss intervention.
• Does Bioma probiotic work for weight loss? — deep-dive on the Bioma probiotic blend (~1,600/mo). Bioma markets a B. lactis + B. longum + B. breve formulation with 100 mg xylooligosaccharide prebiotic and 90 mg tributyrin postbiotic at $26.94-$47.99 per bottle but does NOT disclose specific strain identifiers (Bb-12, HN019, B420). Pooled probiotic + body weight effect is ~0.5-1 kg over months per Borgeraas 2018 (PMID 29047207,Obes Rev, 15 RCTs n=957) and Sadeghi 2024 umbrella review (PMID 39320636, Probiotics Antimicrob Proteins). Strongest single trial — Stenman 2016 (PMID 27810310, EBioMedicine, B420 + polydextrose, n=225) — produced 4.5% body fat reduction but not statistically significant body-weight loss. Akkermansia muciniphila pilot (Depommier 2019, PMID 31263284, Nat Med) was a non-significant -2.27 kg trend. Order-of-magnitude gap to Wegovy/Zepbound is ~20-30x. Grade C for body weight specifically.
• NAD+ for weight loss: evidence vs marketing — deep-dive on NMN, NR, and IV NAD+ drips (~1.8K/mo combined). Yoshino M 2021 NMN (PMID 33888596, Science) improved muscle insulin sensitivity in prediabetic women but produced NO weight loss; Martens 2018 (PMID 29599478, Nat Commun) and Dollerup 2018 (PMID 29992272, Am J Clin Nutr) NR trials in healthy older adults and obese men: no body composition change. IV NAD+ drips ($200-$500/session) have ZERO peer-reviewed RCT support for weight loss. FDA November 2022 NDI/IND-exclusion ruling effectively removed NMN from the US dietary supplement marketplace; NR remains commercially available. The longevity/metabolism/fat-oxidation marketing claims exceed what the published evidence supports.
• Stress, cortisol, and food noise on a GLP-1 — for the ashwagandha context
• Metformin and non-GLP-1 diabetes drugs for weight loss — the prescription comparators
• GLP-1 protein calculator — for the actual evidence-based dietary intervention
• Is sourdough bread good for weight loss? — the bread-specific food question patients ask alongside supplement queries (glycemic index, USDA per-slice macros, GLP-1 compatibility)
• Mexican diet pills: what's actually in them and why you should avoid them — the safety-first companion article on unregulated combination weight-loss products. The DSHEA “dietary supplement” framework that allows the products graded above also enables tainted weight-loss products with undeclared sibutramine (FDA-withdrawn 2010), fenfluramine (FDA-banned 1997), and ephedra alkaloids (FDA-banned 2004) per the FDA Tainted Weight Loss Products list.

Important disclaimer. This article is educational and does not constitute medical advice. Dietary supplements are not FDA-approved for weight loss and may interact with prescription medications. Patients on statins, anticoagulants, antidepressants, thyroid medication, or any GLP-1 receptor agonist should discuss supplement use with their prescribing clinician before starting. Berberine inhibits CYP3A4 and warrants caution with statins (see our berberine article). Green tea extract has rare hepatotoxicity case reports at high doses. Garcinia cambogia has been associated with rare liver injury. Every primary source cited here was independently verified against PubMed on 2026-04-08. Items the verification subagent could not confirm against primary sources (specifically L-lysine and lemon balm for weight loss) are explicitly flagged as UNVERIFIED rather than paraphrased.